<record>
  <datafield tag="024" ind1="7" ind2=" ">
    <subfield code="a">10.1016/j.chaos.2017.03.002</subfield>
    <subfield code="2">DOI</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">Liu, Peng</subfield>
    <subfield code="v">Department of Mechanics, Tianjin University, Tianjin, 300354, PR China</subfield>
    <subfield code="v">Tianjin Key Laboratory of Nonlinear Dynamics and Chaos Control, Tianjin, 300072, PR China</subfield>
    <subfield code="m">liupeng823@tju.edu.cn</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Dynamics of a tumor-immune model considering targeted chemotherapy</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2017-05</subfield>
    <subfield code="t">published</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
    <subfield code="a">7</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">Considering the targeted chemotherapy, a mathematical model of tumor-immune system was constructed on the basis of de Pillis’s model. In this paper, we conducted qualitative analysis on the mathematical model, including the positivity and boundedness of solutions, local stability and global stability of equilibrium solutions. Some numerical simulations were given to illustrate the analytic results. Comparing the targeted chemotherapy model with regular chemotherapy model, we found that the targeted chemotherapy was benefit to kill tumor cells.</subfield>
    <subfield code="9">Elsevier</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="f">Elsevier Ltd</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">Tumor-immune model</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">Chemotherapy</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">Stability</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">Bifurcation analysis</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Liu, Xijun</subfield>
    <subfield code="v">Department of Mechanics, Tianjin University, Tianjin, 300354, PR China</subfield>
    <subfield code="v">Tianjin Key Laboratory of Nonlinear Dynamics and Chaos Control, Tianjin, 300072, PR China</subfield>
  </datafield>
  <datafield tag="773" ind1=" " ind2=" ">
    <subfield code="p">Chaos</subfield>
    <subfield code="c">7-13</subfield>
    <subfield code="v">Solitons and Fractals: the interdisciplinary journal of Nonlinear Science98</subfield>
    <subfield code="y">2017</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">HEP</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">Citeable</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">Published</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Trotti, A.</subfield>
    <subfield code="h">Colevas, A.D.</subfield>
    <subfield code="h">Setser, A.</subfield>
    <subfield code="h">Rusch, V.</subfield>
    <subfield code="h">Jaques, D.</subfield>
    <subfield code="h">Budach, V.</subfield>
    <subfield code="t">Ctcae v3. 0: development of a comprehensive grading system for the adverse effects of cancer treatment, , vol. 13</subfield>
    <subfield code="p">Elsevier</subfield>
    <subfield code="v">vol. 13</subfield>
    <subfield code="y">2003</subfield>
    <subfield code="o">1</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Herman, S.E.</subfield>
    <subfield code="h">Gordon, A.L.</subfield>
    <subfield code="h">Hertlein, E.</subfield>
    <subfield code="h">Ramanunni, A.</subfield>
    <subfield code="h">Zhang, X.</subfield>
    <subfield code="h">Jaglowski, S.</subfield>
    <subfield code="t">Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by pci-32765</subfield>
    <subfield code="v">117</subfield>
    <subfield code="y">2011</subfield>
    <subfield code="o">2</subfield>
    <subfield code="s">Blood,117,6287</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Zhang, J.</subfield>
    <subfield code="h">Yang, P.L.</subfield>
    <subfield code="h">Gray, N.S.</subfield>
    <subfield code="t">Targeting cancer with small molecule kinase inhibitors</subfield>
    <subfield code="v">9</subfield>
    <subfield code="y">2009</subfield>
    <subfield code="o">3</subfield>
    <subfield code="s">Nat Rev Cancer,9,28</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Shangary, S.</subfield>
    <subfield code="h">Wang, S.</subfield>
    <subfield code="t">Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: a novel approach for cancer therapy</subfield>
    <subfield code="v">49</subfield>
    <subfield code="y">2009</subfield>
    <subfield code="o">4</subfield>
    <subfield code="s">Annu Rev Pharmacol Toxicol,49,223</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Monroig, P.d.C.</subfield>
    <subfield code="h">Chen, L.</subfield>
    <subfield code="h">Zhang, S.</subfield>
    <subfield code="h">Calin, G.A.</subfield>
    <subfield code="t">Small molecule compounds targeting mirnas for cancer therapy</subfield>
    <subfield code="v">81</subfield>
    <subfield code="y">2015</subfield>
    <subfield code="o">5</subfield>
    <subfield code="s">Adv Drug Deliv Rev,81,104</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Huang, P.</subfield>
    <subfield code="h">Wang, D.</subfield>
    <subfield code="h">Su, Y.</subfield>
    <subfield code="h">Huang, W.</subfield>
    <subfield code="h">Zhou, Y.</subfield>
    <subfield code="h">Cui, D.</subfield>
    <subfield code="t">Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug–drug conjugate for cancer therapy</subfield>
    <subfield code="v">136</subfield>
    <subfield code="y">2014</subfield>
    <subfield code="o">6</subfield>
    <subfield code="s">J.Am.Chem.Soc.,136,11748</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Pérez-Herrero, E.</subfield>
    <subfield code="h">Fernández-Medarde, A.</subfield>
    <subfield code="t">Advanced targeted therapies in cancer: drug nanocarriers, the future of chemotherapy</subfield>
    <subfield code="v">93</subfield>
    <subfield code="y">2015</subfield>
    <subfield code="o">7</subfield>
    <subfield code="s">Eur J Pharm Biopharm,93,52</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Brannon-Peppas, L.</subfield>
    <subfield code="h">Blanchette, J.O.</subfield>
    <subfield code="t">Nanoparticle and targeted systems for cancer therapy</subfield>
    <subfield code="v">64</subfield>
    <subfield code="y">2012</subfield>
    <subfield code="o">8</subfield>
    <subfield code="s">Adv Drug Deliv Rev,64,206</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Glassman, P.M.</subfield>
    <subfield code="h">Balthasar, J.P.</subfield>
    <subfield code="t">Mechanistic considerations for the use of monoclonal antibodies for cancer therapy</subfield>
    <subfield code="v">11</subfield>
    <subfield code="y">2014</subfield>
    <subfield code="o">9</subfield>
    <subfield code="s">Cancer Biol Med,11,20</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Weiner, G.J.</subfield>
    <subfield code="t">Building better monoclonal antibody-based therapeutics</subfield>
    <subfield code="v">15</subfield>
    <subfield code="y">2015</subfield>
    <subfield code="o">10</subfield>
    <subfield code="s">Nat Rev Cancer,15,361</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Delalat, B.</subfield>
    <subfield code="h">Sheppard, V.C.</subfield>
    <subfield code="h">Ghaemi, S.R.</subfield>
    <subfield code="h">Rao, S.</subfield>
    <subfield code="h">Prestidge, C.A.</subfield>
    <subfield code="h">McPhee, G.</subfield>
    <subfield code="t">Targeted drug delivery using genetically engineered diatom biosilica</subfield>
    <subfield code="v">6</subfield>
    <subfield code="y">2015</subfield>
    <subfield code="o">11</subfield>
    <subfield code="s">Nat Commun,6</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Kuznetsov, V.A.</subfield>
    <subfield code="h">Makalkin, I.A.</subfield>
    <subfield code="h">Taylor, M.A.</subfield>
    <subfield code="h">Perelson, A.S.</subfield>
    <subfield code="t">Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis</subfield>
    <subfield code="v">56</subfield>
    <subfield code="y">1994</subfield>
    <subfield code="o">12</subfield>
    <subfield code="s">Bull.Math.Biol.,56,295</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Kirschner, D.</subfield>
    <subfield code="h">Panetta, J.C.</subfield>
    <subfield code="t">Modeling immunotherapy of the tumor–immune interaction</subfield>
    <subfield code="v">37</subfield>
    <subfield code="y">1998</subfield>
    <subfield code="o">13</subfield>
    <subfield code="s">J.Math.Biol.,37,235</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Kuznetsov, V.A.</subfield>
    <subfield code="h">Knott, G.D.</subfield>
    <subfield code="t">Modeling tumor regrowth and immunotherapy</subfield>
    <subfield code="v">33</subfield>
    <subfield code="y">2001</subfield>
    <subfield code="o">14</subfield>
    <subfield code="s">Math Comput Model,33,1275</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">de Pillis, L.G.</subfield>
    <subfield code="h">Radunskaya, A.E.</subfield>
    <subfield code="h">Wiseman, C.L.</subfield>
    <subfield code="t">A validated mathematical model of cell-mediated immune response to tumor growth</subfield>
    <subfield code="v">65</subfield>
    <subfield code="y">2005</subfield>
    <subfield code="o">15</subfield>
    <subfield code="s">Cancer Res,65,7950</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">de Pillis, L.G.</subfield>
    <subfield code="h">Gu, W.</subfield>
    <subfield code="h">Radunskaya, A.E.</subfield>
    <subfield code="t">Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations</subfield>
    <subfield code="v">238</subfield>
    <subfield code="y">2006</subfield>
    <subfield code="o">16</subfield>
    <subfield code="s">J.Theor.Biol.,238,841</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">ForyŚ, U.</subfield>
    <subfield code="h">Waniewski, J.</subfield>
    <subfield code="h">Zhivkov, P.</subfield>
    <subfield code="t">Anti-tumor immunity and tumor anti-immunity in a mathematical model of tumor immunotherapy</subfield>
    <subfield code="v">14</subfield>
    <subfield code="y">2006</subfield>
    <subfield code="o">17</subfield>
    <subfield code="s">J Biol Syst,14,13</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">de Pillis, L.G.</subfield>
    <subfield code="h">Gu, W.</subfield>
    <subfield code="h">Fister, K.R.</subfield>
    <subfield code="h">Head, T.</subfield>
    <subfield code="h">Maples, K.</subfield>
    <subfield code="h">Murugan, A.</subfield>
    <subfield code="t">Chemotherapy for tumors: an analysis of the dynamics and a study of quadratic and linear optimal controls</subfield>
    <subfield code="v">209</subfield>
    <subfield code="y">2007</subfield>
    <subfield code="o">18</subfield>
    <subfield code="s">Math.Biosci.,209,292</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">López, Á.G.</subfield>
    <subfield code="h">Seoane, J.M.</subfield>
    <subfield code="h">Sanjuán, M.A.</subfield>
    <subfield code="t">A validated mathematical model of tumor growth including tumor–host interaction, cell-mediated immune response and chemotherapy</subfield>
    <subfield code="v">76</subfield>
    <subfield code="y">2014</subfield>
    <subfield code="o">19</subfield>
    <subfield code="s">Bull.Math.Biol.,76,2884</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Sharma, S.</subfield>
    <subfield code="h">Samanta, G.</subfield>
    <subfield code="t">Analysis of the dynamics of a tumor–immune system with chemotherapy and immunotherapy and quadratic optimal control</subfield>
    <subfield code="v">24</subfield>
    <subfield code="y">2016</subfield>
    <subfield code="o">20</subfield>
    <subfield code="s">Differ Equ Dynam Syst,24,149</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Pang, L.</subfield>
    <subfield code="h">Zhao, Z.</subfield>
    <subfield code="h">Song, X.</subfield>
    <subfield code="t">Cost-effectiveness analysis of optimal strategy for tumor treatment</subfield>
    <subfield code="v">87</subfield>
    <subfield code="y">2016</subfield>
    <subfield code="o">21</subfield>
    <subfield code="s">Chaos Solitons Fractals,87,293</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Valle, P.A.</subfield>
    <subfield code="h">Starkov, K.E.</subfield>
    <subfield code="h">Coria, L.N.</subfield>
    <subfield code="t">Global stability and tumor clearance conditions for a cancer chemotherapy system</subfield>
    <subfield code="v">40</subfield>
    <subfield code="y">2016</subfield>
    <subfield code="o">22</subfield>
    <subfield code="s">Commun.Nonlinear Sci.Numer.Simul.,40,206</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Castillo-Chavez, C.</subfield>
    <subfield code="h">Thieme, H.R.</subfield>
    <subfield code="t">Asymptotically autonomous epidemic models</subfield>
    <subfield code="v">1</subfield>
    <subfield code="y">1995</subfield>
    <subfield code="o">23</subfield>
    <subfield code="s">Math Popul Dynam,1,33</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Krishchenko, A.</subfield>
    <subfield code="t">Localization of invariant compact sets of dynamical systems</subfield>
    <subfield code="v">41</subfield>
    <subfield code="y">2005</subfield>
    <subfield code="o">24</subfield>
    <subfield code="s">Differ Eq,41,1669</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Pinho, S.T.</subfield>
    <subfield code="h">Bacelar, F.S.</subfield>
    <subfield code="h">Andrade, R.F.</subfield>
    <subfield code="h">Freedman, H.</subfield>
    <subfield code="t">A mathematical model for the effect of anti-angiogenic therapy in the treatment of cancer tumours by chemotherapy</subfield>
    <subfield code="v">14</subfield>
    <subfield code="y">2013</subfield>
    <subfield code="o">25</subfield>
    <subfield code="s">Nonlinear Anal.Real World Appl.,14,815</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Yu, P.</subfield>
    <subfield code="t">Closed-form conditions of bifurcation points for general differential equations</subfield>
    <subfield code="v">15</subfield>
    <subfield code="y">2005</subfield>
    <subfield code="o">26</subfield>
    <subfield code="s">Int J Bifurcation Chaos,15,1467</subfield>
  </datafield>
  <datafield tag="FFT" ind1=" " ind2=" ">
    <subfield code="a">/afs/cern.ch/project/inspire/uploads/elsevier/consyn/consyn-files/0960-0779/S0960077917X00040/S0960077917300553/S0960077917300553.xml</subfield>
    <subfield code="t">Elsevier</subfield>
    <subfield code="o">HIDDEN</subfield>
  </datafield>
</record>